US60770K1079
US60770K1079
Moderna, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 89.83B EUR | 27.94B EUR | 20.15B EUR | 11.62B EUR |
Enterprise Value | 74.8B EUR | 27.51B EUR | 19.54B EUR | 10.33B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -50.7x | -- | -- | -- |
Price to Sales | 40.32x | 12.64x | 9.14x | 6.4x |
Price to Book | 13.28x | 4.13x | 2.72x | 1.34x |
EV/Revenue | 33.57x | 12.45x | 8.86x | 5.69x |
EV/EBITDA | -34.08x | -- | -- | -- |
Price to FCF (P/FCF) | 300.18x | -- | -- | -- |
EV/FCF | 249.95x | -- | -- | -- |
FCF Yield | 0.33% | -4.45% | -7.96% | -7.84% |